Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107481 · ClinicalTrials.gov registry record · Phase 4
Acetaminophen IV vs Hydromorphone IV in the ED
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 220
- Enrollment target
NCT03107481 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 220 participants.
The verdict
NCT03107481, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 220 participants
- Enrollment target
Study Summary
The purpose of the current study is to compare the analgesic efficacy of intravenous acetaminophen and intravenous hydromorphone in the treatment of acute pain in the ED.
Interventions
- DRUG Acetaminophen
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2017-06-04 |
| Est. Completion | 2017-11-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107481
The ClinicalTrials.gov registry entry for NCT03107481 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT03107481 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03107481 about?
NCT03107481 is a clinical study titled "Acetaminophen IV vs Hydromorphone IV in the ED". The purpose of the current study is to compare the analgesic efficacy of intravenous acetaminophen and intravenous hydromorphone in the treatment of acute pain in the ED.
What is the current status of trial NCT03107481?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2017-06-04. Estimated completion is 2017-11-14.
What interventions are being tested in trial NCT03107481?
The interventions under investigation include: Acetaminophen (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT03107481?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.